Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Clin Exp Hypertens. 2011;33(4):223-30. doi: 10.3109/10641963.2011.583967.
The Renin-Angiotensin System (RAS) modulates blood pressure, this study focuses upon Angiotensin-(1-7) in the RVLM. The objective of the present study was to determine whether Ang-(1-7) in the RVLM contributes to the maintenance of BP in the rat model of hypertension. Male Wistar-Kyoto rats (WKYs) and spontaneously hypertensive rats (SHRs) used. SHRs and WKYs monitored for BP, HR, and renal sympathetic nerve activity (RSNA). Rats injected with Ang (1-7), Mas receptor antagonist A-779, and ACE2 inhibitor DX600. They also performed Western Blot analysis for Mas receptors in SHR and WKY. Unilaterial Ang-(1-7) microinjection inducted a significantly greater increase in MAP in SHR than WKY. Bilateral A-779 microinjection induced a significantly greater decrease in AP and renal sympathetic nerve activity in SHR than WKY. Bilateral DX600 microinjection induced a significantly greater decrease in AP in SHR than in WKY. These results suggest that endogenous Ang-(1-7) in the RVLM contributes to maintain AP and renal sympathetic nerve activity in both SHR and WKY, and that its activity is likely enhanced in SHR. We could probably do a similar study in WR and SEDs, however, it would probably just lead to a somewhat similar result to this SHR v. WKY study. This study suggests that there is a greater deal of sympathoexcitation for any given input in the case of non-normotensive conditions.
Posted by Max
Posted by Max
No comments:
Post a Comment